Skip to main content
  • About
  • Careers
  • Locations
ArentFox Schiff

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
Search the Site Search the Site
Toggle Main Menu

Main navigation

  • Attorneys
  • Industries & Practices
  • Insights
    • Blogs
    • Alerts
    • Events
    • News
    • The Fine Print
    • Fashion Counsel
    • Press Releases
    • Health Care Counsel Blog
    • Managing Automotive Blog
    • AI Law Blog
    • Longevity Lens
    • Trade Secrets Case Watch
    • Trump’s Policy Playbook
    • Consumer Products Watch
    • Customs & Import Compliance Blog
    • Environmental Law Advisor
    • Energy & Cleantech Counsel
    • The In-House Advisor
    • International Arbitration & Dispute Resolution Blog
    • Investigations Blog
    • National Security Counsel
    • Privacy Counsel

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Client Payments
    • Subscribe

Search

Breadcrumb

  1. Insights

Emily M. Cowley’s Insights

163 total results. Page 1 of 14.

Alerts
DOJ Moves FDA Approved and Medical Marijuana to Schedule III
April 30, 2026
Events
2026 Chicago Pharma Forum
March 30, 2026
Alerts
Navigating the 2026 Life Sciences Legal Landscape
March 12, 2026
Alerts
NDSee You in 2033: FDA’s 12‑Digit NDC Is Coming
March 6, 2026
Alerts
High Standards: Protecting Workers in Cannabis Cultivation and Manufacturing
March 2, 2026
Alerts
Top Issues in the Cannabis Industry for 2026
February 17, 2026
Events
Webinar: FDA Regulatory Update Series for Cosmetics & Personal Care Products: Spotlight on Talc-Asbestos Testing and What Comes Next
February 9, 2026
Alerts
New Draft Guidance Addresses FDA’s Records Access Authority for Cosmetics Under MoCRA
January 29, 2026
Alerts
Model Behavior: FDA and EMA’s Guide to Good AI in Drug Development
January 23, 2026
Alerts
FDA Issues Updated Guidance on Low-Risk General Wellness Devices and Clinical Decision Support Software
January 14, 2026
Alerts
MoCRA Marches On: FDA Issues Draft Guidance on Mandatory Cosmetic Recalls
January 9, 2026
Alerts
FDA Proposes First New Sunscreen Active Ingredient in Two Decades
January 5, 2026

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • …
  • Next page Next ›
  • Last page Last »

Footer

  • About
    • Leadership
    • Alumni
    • Diversity
    • Pro Bono
  • Careers
    • Attorney Opportunities
    • Professional Opportunities
    • Summer Program
  • Locations
    • Washington, DC
    • Chicago
    • New York
    • Los Angeles
    • Boston
    • San Francisco
    • Lake Forest
    • Ann Arbor
    • Decentraland
  • Contact
    • Client Payments
    • Subscribe

Social

Linkedin Twitter Youtube

Sub footer

  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Accessibility
  • Non Discrimination

© Copyright 2026 ArentFox Schiff LLP. All Rights Reserved.

Back to Top